Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience

OBJECTIVE: Antimicrotubular agents are among the most commonly used classes of chemotherapeutic agents, but the risk of cardiovascular adverse events (CVAEs) remains unclear. Our objective was to study the CVAEs associated with antimicrotubular agents. METHODS: The Food and Drug Administration’s Adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Batra, Akshee, Patel, Brijesh, Addison, Daniel, Baldassarre, Lauren A, Desai, Nihar, Weintraub, Neal, Deswal, Anita, Hussain, Zeeshan, Brown, Sherry-Ann, Ganatra, Sarju, Agarwala, Vivek, Parikh, Purvish M, Fradley, Michael, Ghosh, Arjun, Guha, Avirup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Special Populations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710909/
https://www.ncbi.nlm.nih.gov/pubmed/34952868
http://dx.doi.org/10.1136/openhrt-2021-001849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710909/
https://www.ncbi.nlm.nih.gov/pubmed/34952868
http://dx.doi.org/10.1136/openhrt-2021-001849

Ejemplares similares